Quantitative cell signaling analysis for cetuximab sensitivity prediction in colorectal cancer

被引：0
|
作者：
Teppei, Matsuo
Nishizuka, Satoshi
Lwaya, Takeshi
Ishida, Kazushige
Noda, Hironobu
Ikeda, Miyuki
Kozai, Megumi
Wakabayashi, Go
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-4146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4146
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenografts
    Perron, Umberto
    Grassi, Elena
    Chatzipli, Aikaterini
    Viviani, Marco
    Karakoc, Emre
    Trastulla, Lucia
    Brochier, Lorenzo M.
    Isella, Claudio
    Zanella, Eugenia R.
    Klett, Hagen
    Molineris, Ivan
    Schueler, Julia
    Esteller, Manel
    Medico, Enzo
    Conte, Nathalie
    Mcdermott, Ultan
    Trusolino, Livio
    Bertotti, Andrea
    Iorio, Francesco
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [22] NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer
    Guang Yang
    Ling Huang
    Hongtao Jia
    Batuer Aikemu
    Sen Zhang
    Yanfei Shao
    Hiju Hong
    Galiya Yesseyeva
    Chenxing Wang
    Shuchun Li
    Jing Sun
    Minhua Zheng
    Junjun Ma
    Oncogene, 2021, 40 : 5993 - 6006
  • [23] Quantitative Analysis of the Rewiring of Signaling Pathways to Alter Cancer Cell Fate
    Schmitz, Richard M.
    Willerth, Stephanie M.
    van Rensburg, Gerrit
    Edwards, Roderick
    JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING, 2020, 40 (01) : 41 - 52
  • [24] Quantitative Analysis of the Rewiring of Signaling Pathways to Alter Cancer Cell Fate
    Richard M. Schmitz
    Stephanie M. Willerth
    Gerrit van Rensburg
    Roderick Edwards
    Journal of Medical and Biological Engineering, 2020, 40 : 41 - 52
  • [25] Single-cell sequencing analysis reveals cetuximab resistance mechanism and salvage strategy in colorectal cancer
    Chen, Shiyun
    Tan, Zhaoli
    Wu, Xiaojie
    Lin, Yanli
    Li, Xiang
    Cui, Yumeng
    Man, Weiling
    Pang, Fang
    Li, Yanghua
    Shi, Faliang
    Han, Lu
    Gou, Miaomiao
    Zhou, Li
    Wang, Zhikuan
    Wang, Youliang
    Dai, Guanghai
    CLINICAL AND TRANSLATIONAL MEDICINE, 2025, 15 (01):
  • [26] Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction
    Papaccio, Federica
    Garcia-Mico, Blanca
    Gimeno-Valiente, Francisco
    Cabeza-Segura, Manuel
    Gambardella, Valentina
    Gutierrez-Bravo, Maria Fernanda
    Alfaro-Cervello, Clara
    Martinez-Ciarpaglini, Carolina
    Rentero-Garrido, Pilar
    Zuniga-Trejos, Sheila
    Carbonell-Asins, Juan Antonio
    Fleitas, Tania
    Rosello, Susana
    Huerta, Marisol
    del Pino, Manuel M. Sanchez M.
    Sabater, Luis
    Roda, Desamparados
    Tarazona, Noelia
    Cervantes, Andres
    Castillo, Josefa
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [27] “Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”
    Federica Papaccio
    Blanca García-Mico
    Francisco Gimeno-Valiente
    Manuel Cabeza-Segura
    Valentina Gambardella
    María Fernanda Gutiérrez-Bravo
    Clara Alfaro-Cervelló
    Carolina Martinez-Ciarpaglini
    Pilar Rentero-Garrido
    Sheila Zúñiga-Trejos
    Juan Antonio Carbonell-Asins
    Tania Fleitas
    Susana Roselló
    Marisol Huerta
    Manuel M. Sánchez del Pino
    Luís Sabater
    Desamparados Roda
    Noelia Tarazona
    Andrés Cervantes
    Josefa Castillo
    Journal of Experimental & Clinical Cancer Research, 42
  • [28] Cetuximab - In the treatment of metastatic colorectal cancer
    Reynolds, NA
    Wagstaff, AJ
    DRUGS, 2004, 64 (01) : 109 - 118
  • [29] Cetuximab for the treatment of patients with colorectal cancer
    Jim Cassidy
    Nature Clinical Practice Oncology, 2008, 5 : 310 - 311
  • [30] Cetuximab for Metastatic Colorectal Cancer.
    Spiro, Howard
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (01): : 95 - 95
12345